Polio Eradication

          

*     VPD Surveillance Bulletins

*     SEARO/IVD Weekly VPD Update

*     SEARO/IVD Monthly VPD Update

*     Resources

Tremendous progress has been made in the global fight against polio since 1988, when the World Health Assembly resolved to eradicate the disease.

In WHO’s South-East Asia Region (SEAR),  seven  out of eleven Member States have been able to successfully interrupt transmission of wild poliovirus for at least four years, with India being the only endemic country, and Indonesia, Nepal  and Bangladesh, suffering recent importations of wild poliovirus.  Overall, the number of cases of polio in the Region has declined by more than 94%, from a reported 25 253 cases (Types 1, 2 and 3) in 1988 to 134 laboratory confirmed cases (Types 1 and 3) in only one country, India, in 2004.

As of  March  200 6 , India  detected  only 66  polio cases  in 2005 compared to  134  in 2004 and, is still in a favourable position to halt polio transmission this year, especially if it maintains the current levels of quality in the implementation of its eradication strategies and the highly sensitive surveillance. A number of initiatives have been implemented in India this year to intensify efforts to interrupt transmission of wild poliovirus; advocacy efforts have been strengthened, monovalent oral polio vaccine (mOPV1) has been introduced and used in campaigns in high-risk areas, new strategies are being employed to reach underserved populations, and finally there has been a greater focus on transit sites (including railways, bus stations, ferries, markets, religious fairs) during campaigns.

The regional eradication programme faced a set back in April 2005, when for the first time in 10 years, the surveillance network in Indonesia detected and reported a wild poliovirus type 1 case in Giri Jaya village, Sukabumi District, West Java.  The WHO Global Specialised Polio Laboratory in Mumbai has since confirmed that the virus strain was very closely related to the viruses responsible for the polio outbreaks in Yemen and Sudan and also to the viruses found in Saudi Arabia in late 2004.  Since the detection of this index case, the number of affected children has rapidly increased to 287 (October  2005), with cases also being detected in Central Java, East Java, Banten, Jakarta,  Lumpung, South Sumatra, Riau, North Sumatra and Aceh, the province affected by last year’s tsunami disaster.

As a response the Government of Indonesia has conducted an Outbreak Response Immunization (ORI), followed by two rounds of mopping-up immunization for all children aged less than five years in West Java, Banten and Jakarta Provinces.  Following the completion of the second mop-up round, the government conducted two rounds of National Immunization Days (NIDs) in August and September, 2005.   The third NID will be launched on the 30 November, 2005. The rapid spread and extent of the new wild poliovirus circulation has necessitated WHO/SEARO/IVD to dramatically expand the scope of its technical support to the Government of Indonesia. 

An imported case of wild poliovirus from India was reported in Nepal in September 2005.  As a response, Nepal is conducting three rounds of mop-ups in the five districts around the case and two rounds in other districts along the India border.  Nepal has also responded by strengthening AFP surveillance activities.  

On March 8, 2006, Bangladesh reported its first polio case since year 2000 from Chandur district in Chittagong.   An immediate ORI was conducted in the surrounding area and the government is currently devising its response plan with support from partners, including WHO.

The other countries in the Region, ie Bhutan, the Democratic People’s Republic of Korea, Maldives, Myanmar, Sri Lanka, Thailand and Timor Leste have all been polio-free for more than four years. 

In addition to assisting Member States with polio immunization activities, WHO continues to provide the 11 countries in SEAR, especially India, Nepal, Bangladesh, Indonesia and Myanmar, with acute flaccid paralysis (AFP) surveillance support.

 

||| | ||